Kenneth Aldape, Kevin M Brindle, Louis Chesler, Rajesh Chopra, Amar Gajjar, Mark R Gilbert, Nicholas Gottardo, David H Gutmann, Darren Hargrave, Eric C Holland, David T W Jones, Johanna A Joyce, Pamela Kearns, Mark W Kieran, Ingo K Mellinghoff, Melinda Merchant, Stefan M Pfister, Steven M Pollard, Vijay Ramaswamy, Jeremy N Rich, Giles W Robinson, David H Rowitch, John H Sampson, Michael D Taylor, Paul Workman, Richard J Gilbertson
Despite decades of research, brain tumours remain among the deadliest of all forms of cancer. The ability of these tumours to resist almost all conventional and novel treatments relates, in part, to the unique cell-intrinsic and microenvironmental properties of neural tissues. In an attempt to encourage progress in our understanding and ability to successfully treat patients with brain tumours, Cancer Research UK convened an international panel of clinicians and laboratory-based scientists to identify challenges that must be overcome if we are to cure all patients with a brain tumour...
August 2019: Nature Reviews. Clinical Oncology